Literature DB >> 25858599

[Subcutaneous phaeohyphomycosis caused by Phaeoacremonium parasiticum].

Jose Alayeto Ortega1, Albert Alier Fabregó2, Lluis Puig Verdie2, Maria Luisa Sorli Redo3, Juan Pablo Horcajada Gallego3, M Eugenia Portillo Bordonabe4.   

Abstract

BACKGROUND: From the available literature, it is demonstrated that dematiaceous fungal infections mostly affect immunosuppressed patients. These infections can occur in different forms, from subcutaneous infection to disseminated forms that may compromise the life of the patient. In many cases the infection is related to the inoculation of the microorganism by diverse traumatic mechanisms, which determines the course of the infection to be slower in some cases. CASE REPORT: We describe two cases of phaeohyphomycosis caused by Phaeoacremonium parasiticum: A cancer patient with subcutaneous lesions affecting the left hand and forearm, and a patient who presented with subcutaneous abscesses in the left leg.
CONCLUSIONS: These cases confirm the presence of this type of fungus in Spain. In the second case a combination of amphotericin B lipid complex and posaconazole, together with several surgical resections, were necessary in order to overcome the infection.
Copyright © 2013 Revista Iberoamericana de Micología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Feohifomicosis subcutánea; Kidney transplant; Phaeoacremonium parasiticum; Subcutaneous phaeohyphomycosis; Trasplante renal

Mesh:

Substances:

Year:  2015        PMID: 25858599     DOI: 10.1016/j.riam.2014.10.004

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  1 in total

1.  In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.

Authors:  Hamid Badali; Sadegh Khodavaisy; Hamed Fakhim; G Sybren de Hoog; Jacques F Meis; Anuradha Chowdhary
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.